NexgenRx Inc.
NEGXF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$31.29M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $31.29 Million |
|---|---|
| Enterprise Value | - |
| Annual dividend | $0.01 |
| Dividend yield | 2.47% |
| Earnings per Share | $0.02 |
| Beta | 0.46 |
| Outstanding Shares | 71,117,132 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 18.78 |
|---|---|
| PEG | 10.37 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
August 20, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About NexgenRx Inc.
20 employees
CEO: Ronald C. Loucks
NexgenRx Inc., established in 2003 and based in Toronto, Canada, functions as a third-party administrator for health benefit plans. The company's primary role involves efficiently managing, adjudicating, and processing payments for presc...